uncontrolled – Page 4 – Communicable Diseases Research

South African Thoracic Society statement on obstructive airways disease and COVID-19

Guideline

Published on 2020-10-132022-10-28
Journal: African Journal of Thoracic and Critical Care Medicine [Category] COVID-19,

Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?

Review

Published on 2020-08-242022-10-28
Journal: Biology [Category] COVID-19,

[키워드] acute respiratory syndrome adoptive cell-based therapy anti-neoplastic regimen Antigen caused cells chimeric clinical trial clinical trials Community confirmed case coronavirus coronavirus disease COVID-19 Cytokine storm death deregulation Extracellular Extracellular vesicles global pandemic high mortality Host immune Immune cell immunomodulatory immunomodulatory drugs Infection lack Mesenchymal stem cells modality Multiple natural killer outcome pharmaceutical intervention Protective race receptors reduce regenerative regimen regimens risk running SARS-CoV-2 SARS-CoV-2 pathogenesis selected shown Spread Stem cell therapy the SARS-CoV-2 therapeutic therapeutic strategy therapy Treatment treatment strategy uncontrolled Vaccine
[DOI] 10.3390/biology9090243 PMC 바로가기 [Article Type] Review

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

Review

Published on 2020-07-212022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS,

[키워드] activated activity anti-inflammatory drug antioxidant Antiviral antiviral activity Autoimmune diseases B cell benefit clinical trials coronavirus coronavirus disease COVID-19 COVID-19 patients cytokine Cytokine storm syndrome Cytokines develop downregulate downstream Effect effective Efficacy EGCG expression green tea extract homeostasis hyper-inflammation immunological Infection inflammatory bowel diseases Inflammatory mediators ingredient inhibit JAK/STAT management multiple sclerosis NF-κB NF-κB nuclear Pathways Patient Pneumonia pro-inflammatory signaling Registered respiratory rheumatoid arthritis Safe SARS-CoV-2 scenario severe COVID-19 Signaling therapy Transcription transcription factors uncontrolled
[DOI] 10.3390/ijms21145171 PMC 바로가기 [Article Type] Review

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism

Clinical Practice Guidance

Published on 2020-07-192022-10-31
Journal: European Journal of Endocrinology [Category] COVID-19, SARS,

A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial”

Letter

Published on 2020-06-262022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Acute respiratory failure Administered Admission Adverse age Aneurysm Antibiotics atherosclerotic baseline blind blood pressure Brain cardiovascular disease carotid cerebrovascular accident cervical spine chronic clinical trial Complete congestive heart failure Consent control group Controlled trial Coronary artery disease cough COVID-19 criteria current cytokine Cytokine storm Day decrease Delay Disabled disease dissemination distress dose electrical element eligible enrolled evaluate expected Follow-up Gender growth Healthcare provider hemorrhage history hospital hospital discharge ICU admission Informed Initiation interleukin interleukin 6 Intervention less mechanical ventilation mechanical ventilator Mild moderate Mortality Myocardial infarction nerve stimulation number O2 Saturation objective occur Older open label outcome oxygen Oxygen level Oxygen therapy parallel group participant Patient patients with moderate per day persist positive prophylactically protocol pulmonary randomisation randomised randomised controlled randomised controlled trial randomization Randomized recruited recruitment reduce reduction regimen Registered required Research respiratory Respiratory failure Sample size Sapphire saturation second dose secondary severity Shortness of breath SOC Spain Standard Standard of care status storm stratified study group Study protocol subject supplemental oxygen supplemental oxygen requirement tested trauma Treatment tumor necrosis factor tumors uncontrolled Vague neurostimulation Valencia Ventilation ventilatory support website women
[DOI] 10.1186/s13063-020-04486-w PMC 바로가기 [Article Type] Letter

2019-nCoV: Measures Adopted at the Departments of Oral Surgery and Radiology during the Period of an Uncontrolled Transmission Increase

Communication

Published on 2020-06-082022-10-31
Journal: Dentistry Journal [Category] COVID-19,

The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-052022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 24 hours acid Administered Affect analyst Anti-viral anticipated Beijing block block randomization Blood Body Capital cardiovascular system Care center changed Chinese clinical clinical manifestation Clinical outcome Clinical studies clinical trial college Complete condition Consent control group Corona Corona virus cough COVID-19 criteria curative Diagnosis discharge discharged disease Diseases dissemination dose drug Ebola virus element eligibility criteria enrolled expected experimental group Favipiravir female Follow-up form hepatology history hospital include Including Infection Infectious disease Informed inhibit investigators kidney lack lactating women life-threatening liver Loss male Measures mechanism Medicine Mental Disorders Nasopharyngeal swab nasopharyngeal swabs not blinded nucleic acid nucleic acid test number objective open label oral administration outcome outcome assessors Oxygen therapy parallel group participant Participants Patient plan poor compliance positive protocol Public pulmonary randomised randomised controlled trial randomization system Randomized controlled trial Randomly recruited recruitment reduced Regular Reinfection Research researcher respiratory specimen response returned RNA-dependent RNA polymerase routine screening visit second secondary severe adverse events severity severity of symptoms Shenzhen specimens sputum status Study protocol subject Symptom Symptoms System temperature Test tested therapeutic efficacy throat swabs Traditional Treatment treatment for COVID-19 treatment group Trial uncontrolled university variety viral nucleic acid virus Web website Withdrawal Wuhan
[DOI] 10.1186/s13063-020-04430-y PMC 바로가기 [Article Type] Letter